1. Home
  2. Analysis
  3. Cardizem
  4. Telmisartan

Cardizem and Telmisartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Cardizem and Telmisartan together.

The phase IV clinical study analyzes what interactions people who take Cardizem and Telmisartan have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 01, 2023

5 people who take Cardizem and Telmisartan together, and have interactions are studied.

What is Cardizem?

Cardizem has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 27,066 Cardizem users for its effectiveness, alternative drugs and more.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 4,365 Telmisartan users for its effectiveness, alternative drugs and more.

Number of Cardizem and Telmisartan reports submitted per year:

Cardizem and Telmisartan drug interactions.

Common Cardizem and Telmisartan drug interactions by gender *:

female:

  1. Euphoric mood
  2. Hepatomegaly
  3. Hot flush
  4. Pollakiuria
  5. Somnolence
  6. Urinary retention
  7. Asthenia
  8. Blunted affect
  9. Constipation
  10. Diabetes mellitus

male:

  1. Injection site haematoma
  2. Injection site haemorrhage
  3. International normalised ratio increased

Common Cardizem and Telmisartan drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Hepatomegaly
  2. Pollakiuria
  3. Somnolence
  4. Urinary retention
  5. Blunted affect
  6. Constipation
  7. Diabetes mellitus
  8. Diabetic neuropathy
  9. Disturbance in attention
  10. Dry mouth

60+:

  1. Injection site haematoma
  2. Injection site haemorrhage
  3. International normalised ratio increased

* Approximation only. Some reports may have incomplete information.

Do you take Cardizem and Telmisartan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cardizem and Telmisartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cardizem side effects:

Browse all side effects of Cardizem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Telmisartan side effects:

Browse all side effects of Telmisartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cardizem interactions:

Browse all interactions between Cardizem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Telmisartan interactions:

Browse all interactions between Telmisartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride and telmisartan (the active ingredients of Cardizem and Telmisartan, respectively), and Cardizem and Telmisartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cardizem and Telmisartan.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.